With 3000+ Life Sciences & Health R&D companies, 13 Universities, 2100+ ongoing clinical trials, 104.000+ employees and 50 billion euro export value the Netherlands is a major player in the European life sciences industry, with a strong technological position in areas such as human vaccines, biopharmaceuticals and health infrastructure. The Dutch sector owes this position to collaboration, cooperation and coalition building between businesses, research institutes and universities.

The Dutch Life Sciences conference is hosted by organisations and companies of the main life sciences clusters in the Netherlands whose mission is to help realising the further development and growth of the Dutch life sciences industry. The conference provides attendees with an excellent opportunity to network and share ideas with the aim of creating new partnerships and business opportunities. Trends and developments are being addressed by industry experts, entrepreneurs and venture capitalists.